Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide

Elafin as a Predictive Biomarker of Acute Skin Graft-Versus-Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has shown favorable results in the treatment of hematological malignancies. Despite the use of post-transplant cyclophosphamide (PTCy), graft versus host disease (GVHD) remains as one of the main complications in this setting. Since...

Full description

Bibliographic Details
Main Authors: Laura Solán, Diego Carbonell, Paula Muñiz, Nieves Dorado, Elena Landete, María Chicano-Lavilla, Javier Anguita, Jorge Gayoso, Mi Kwon, José Luis Díez-Martín, Carolina Martínez-Laperche, Ismael Buño
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Immunology
Subjects:
haploidentical stem cell transplantation
skin graft versus host disease
prognostic biomarkers
elafin
high-dose cyclophosphamide
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.516078/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.516078/full

Similar Items